INMIVET, Department of Animal Health, School of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Centro de Transfusión Veterinario, Madrid, Spain.
Vet Immunol Immunopathol. 2020 Dec;230:110148. doi: 10.1016/j.vetimm.2020.110148. Epub 2020 Nov 7.
Human leishmaniosis caused by Leishmania infantum is a zoonotic disease, with dogs as the main reservoir in Mediterranean Basin countries. The largest European outbreak of human leishmaniosis declared in the southwestern Madrid region (Spain) is characterized by unusual epidemiological and clinical features, such as the emergence of new wild reservoirs (hares and rabbits), whereas the seroprevalence, infection, and severity of canine leishmaniosis have not substantially changed since the first studies conducted in Madrid before the outbreak. Previous studies reported that L. infantum isolates from the Madrid leishmaniosis focus displayed elevated virulence in in vivo models of infection and increased infectivity in murine target cells. With the aim of studying whether changes in the host-parasite interaction and virulence profile have developed, we first assessed the behaviour of one circulating isolate of the outbreak, IPER/ES/2012/BOS1FL1 (BOS1FL1), compared to that of a well-characterized strain from canine leishmaniosis, MCAN/ES/1996/BCN150 (BCN150), in terms of infection capacity (percentage of infected cells, representing infectivity, and number of amastigotes per infected cell, representing the intensity of infection) in canine monocytes and macrophages. BCN150 displayed significantly higher infectivity (76.82 ± 4.40 vs 38.58 ± 2.19; P < 0.0001) and intensity of infection (3.64 ± 0.13 vs 1.83 ± 0.12; P < 0.0001) than BOS1FL1 when interacting with canine cells. Our ROS induction results did not differ significantly between the two isolates or with the responses previously described for other L. infantum isolates. Paradoxically, increased resilience to hydrogen peroxide exposure was observed for BOS1FL1 (% viability 40.62 ± 5.54 vs 26.37 ± 2.93; P = 0.039). Finally, we demonstrated that a decreased intracellular load of BOS1FL1 was associated with increased IFN-γ (261.21 ± 26.29 vs 69.80 ± 9.02; P = 0.0151) and decreased IL-10 production (165.06 ± 23.87 vs 264.41 ± 30.58; P = 0.0002). In this study, we provide the first detailed insight into the differences between the isolate BOS1FL1 from the outbreak in Madrid and the well-characterized strain BCN150 MON-1 obtained from a dog in their response to interacting with canine cells. However, further studies are necessary to shed light on the immune mechanisms resulting in BOS1FL1 exhibiting less virulent behaviour in canine cells than in cells derived from other host species.
人利什曼病由婴儿利什曼原虫引起,是一种人畜共患病,在环地中海国家中,狗是主要的储存宿主。西班牙马德里西南部地区宣布的欧洲最大规模人利什曼病爆发具有不同寻常的流行病学和临床特征,例如出现了新的野生动物宿主(野兔和兔子),而马德里爆发前首次进行的研究表明,犬利什曼病的血清流行率、感染率和严重程度并没有实质性变化。先前的研究报告称,马德里利什曼病焦点的婴儿利什曼原虫分离株在体内感染模型中表现出更高的毒力,并在小鼠靶细胞中表现出更高的感染性。为了研究宿主-寄生虫相互作用和毒力特征是否发生了变化,我们首先评估了流行地区循环分离株 IPER/ES/2012/BOS1FL1(BOS1FL1)的行为,与来自犬利什曼病的特征良好的菌株 MCAN/ES/1996/BCN150(BCN150)进行了比较,比较了它们在犬单核细胞和巨噬细胞中的感染能力(表示感染性的受感染细胞百分比和每个受感染细胞中的无鞭毛体数量,代表感染强度)。BCN150 与犬细胞相互作用时的感染性(76.82±4.40 vs 38.58±2.19;P<0.0001)和感染强度(3.64±0.13 vs 1.83±0.12;P<0.0001)明显高于 BOS1FL1。我们的 ROS 诱导结果与以前描述的其他婴儿利什曼原虫分离株的反应没有显著差异。矛盾的是,BOS1FL1 对过氧化氢的耐受性增加(存活率 40.62±5.54 vs 26.37±2.93;P=0.039)。最后,我们证明 BOS1FL1 的细胞内载量减少与 IFN-γ(261.21±26.29 vs 69.80±9.02;P=0.0151)的增加和 IL-10 产生的减少(165.06±23.87 vs 264.41±30.58;P=0.0002)有关。在这项研究中,我们首次详细了解了马德里暴发中的分离株 BOS1FL1 与从犬中获得的特征良好的菌株 BCN150 MON-1 之间的差异,在与犬细胞相互作用时,它们的反应不同。然而,需要进一步的研究来阐明导致 BOS1FL1 在犬细胞中的表现出比其他宿主物种来源的细胞更低毒力的免疫机制。